What is the recommended tapering schedule for an adult patient with a history of depression or mood disorder when weaning off Brintellix (vortioxetine) 15 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning Off Brintellix (Vortioxetine) 15 mg

Brintellix 15 mg can be discontinued abruptly without a formal taper, but reducing to 10 mg daily for one week before complete cessation is recommended to minimize potential discontinuation symptoms. 1

FDA-Approved Discontinuation Protocol

The FDA label for vortioxetine provides clear guidance that distinguishes it from many other antidepressants:

  • Vortioxetine can be discontinued abruptly without medical risk 1
  • For doses of 15 mg/day or 20 mg/day: reduce to 10 mg/day for one week prior to full discontinuation if possible 1
  • This one-week step-down is a recommendation for patient comfort, not a medical necessity 1

Why Vortioxetine Differs from Other Antidepressants

Vortioxetine has a unique multimodal mechanism targeting multiple serotonin receptors (5-HT1A, 5-HT1B, 5-HT1D, 5-HT3, 5-HT7) and the serotonin transporter, which may contribute to its more favorable discontinuation profile compared to traditional SSRIs 2. The FDA explicitly states abrupt discontinuation is acceptable, unlike most SSRIs where this approach is discouraged 1.

Practical Tapering Approach

Standard taper (recommended):

  • Week 1: Reduce from 15 mg to 10 mg daily 1
  • Week 2: Discontinue completely 1

If withdrawal symptoms emerge during the standard taper:

  • Extend the 10 mg phase to 2-4 weeks before discontinuation 3
  • Monitor weekly for discontinuation symptoms during tapering 3
  • If severe symptoms occur, pause at current dose until symptoms resolve, then resume slower taper 3

Monitoring for Discontinuation Symptoms

Watch for these potential withdrawal symptoms during and after discontinuation:

  • Neurological: Dizziness, headache, paresthesias 4, 5
  • Psychiatric: Anxiety, irritability, mood changes, insomnia 4, 5
  • Physical: Nausea, fatigue, flu-like symptoms 4, 5
  • Timeline: Symptoms typically emerge within 1-7 days of dose reduction and may last 1-3 weeks 4, 6

Schedule follow-up within 1-2 weeks after complete discontinuation to assess for withdrawal symptoms or return of depressive symptoms 3.

Distinguishing Withdrawal from Depression Relapse

Critical pitfall: Withdrawal symptoms can mimic depression relapse, leading to unnecessary medication reinitiation 4, 6.

Withdrawal symptoms typically:

  • Appear within days of dose reduction 4
  • Include physical symptoms (dizziness, electric shock sensations) not typical of depression 4, 5
  • Improve within 2-3 weeks without treatment 4

Depression relapse typically:

  • Develops gradually over weeks to months 6
  • Lacks prominent physical symptoms 6
  • Requires treatment intervention 6

Adjunctive Support During Discontinuation

Consider these supportive measures if withdrawal symptoms are problematic:

  • Trazodone 25-50 mg at bedtime for insomnia 3
  • Gabapentin 100-300 mg three times daily for anxiety and sleep disturbances 3
  • Clonidine 0.1 mg twice daily to attenuate adrenergic symptoms (anxiety, restlessness) 3

When to Consider Slower Tapering

Extend the taper beyond the standard one-week protocol if the patient:

  • Has been on vortioxetine for more than 2 years 4, 6
  • Has history of severe withdrawal from previous antidepressant discontinuation 4
  • Develops moderate to severe symptoms during the standard taper 3
  • Has significant anxiety about discontinuation 5

For these patients, consider 10% dose reductions monthly rather than the standard one-week taper 3, 4.

Important Caveats

  • The goal is successful discontinuation, not speed - taking 2-3 months is acceptable if needed for tolerability 3
  • Do not confuse brief withdrawal symptoms with treatment failure - resist immediate medication reinitiation unless symptoms persist beyond 3 weeks 4, 6
  • Ensure depression is in sustained remission before attempting discontinuation - patients should be symptom-free for at least 4-9 months 7
  • Consider psychological support during discontinuation, particularly for patients with recurrent depression 6

References

Research

Vortioxetine for the treatment of major depressive disorder.

Expert review of clinical pharmacology, 2014

Guideline

Tapering Schedule for Stimulants and SSRIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mirtazapine Treatment Guidelines for Major Depressive Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How to taper Zoloft (sertraline) and switch to Prozac (fluoxetine)?
What is the recommended tapering schedule for stopping Olanzapine (Zyprexa) to minimize withdrawal symptoms?
Does a patient require tapering off fluoxetine (Prozac) after being on a 20 milligram dose for 2 months?
Do I need to taper off Zoloft (sertraline) 25mg after taking it for a couple of months before switching to Lexapro (escitalopram)?
How to taper diazepam (benzodiazepine) in an elderly female patient who has been on 10mg for years?
What is the best management approach for an older adult with a history of hypertension, diabetes, or atherosclerosis and microvascular changes in the brain?
What is the best tablet for a patient with depression, considering options like Pristiq (desvenlafaxine), Lexapro (escitalopram), Zoloft (sertraline), and Brintellix (vortioxetine)?
What are the potential causes and further evaluation steps for a patient with significant unplanned weight loss, low vitamin B12 (B12) levels despite oral supplementation, daily bloating, exhaustion, and laboratory results showing mildly low protein, globulin, and white cell count (WCC), high ferritin, and vitamin D levels, with a planned investigation for celiac disease?
What is the best approach to manage a patient presenting with a boil, considering treatment options and potential complications?
What is the appropriate management for an adult patient with a history of hypertension, presenting with hyperaldosteronism and hyporeninemia?
Who manages spine arthritis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.